Efficacy News and Research

RSS
Microbiologists identify staph-killing compound that may be effective for osteomyelitis

Microbiologists identify staph-killing compound that may be effective for osteomyelitis

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

UCLA researchers develop treatment approach for breast cancer metastasized to brain

UCLA researchers develop treatment approach for breast cancer metastasized to brain

August edition of NPS RADAR includes reviews for new medicines listed on PBS

August edition of NPS RADAR includes reviews for new medicines listed on PBS

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Viropharma announces financial results for second quarter of 2013

Viropharma announces financial results for second quarter of 2013

Novocure uses NovoTTF therapy to treat first recurrent glioblastoma tumor patient

Novocure uses NovoTTF therapy to treat first recurrent glioblastoma tumor patient

Pharmanest announces positive results from SHACT Phase II study

Pharmanest announces positive results from SHACT Phase II study

Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC

Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

Naurex receives new U.S. patent for its lead compound, GLYX-13

Naurex receives new U.S. patent for its lead compound, GLYX-13

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Rapamycin extends mice lifespan but has limited effects on aging

Rapamycin extends mice lifespan but has limited effects on aging

Takeda unbinds Phase 3 study of orteronel in patients with mCRPC that progressed post-chemotherapy

Takeda unbinds Phase 3 study of orteronel in patients with mCRPC that progressed post-chemotherapy

New technology enables all of the world's crops to take nitrogen from the air

New technology enables all of the world's crops to take nitrogen from the air

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Silk implants placed in brain of animals may help stop progression of epilepsy

Silk implants placed in brain of animals may help stop progression of epilepsy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.